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Abstract: In many health care systems globally, cancer care is driven by multidisciplinary cancer 
teams (MDTs). A large number of studies in the past few years and across different literature 
have been performed to better understand how these teams work and how they manage patient 
care. The aim of our literature review is to synthesize current scientific and clinical understand-
ing on cancer MDTs and their organization; this, in turn, should provide an up-to-date summary 
of the current knowledge that those planning or leading cancer services can use as a guide for 
service implementation or improvement. We describe the characteristics of an effective MDT 
and factors that influence how these teams work. A range of factors pertaining to teamwork, 
availability of patient information, leadership, team and meeting management, and workload 
can affect how well MDTs are implemented within patient care. We also review how to assess 
and improve these teams. We present a range of instruments designed to be used with cancer 
MDTs – including observational tools, self-assessments, and checklists. We conclude with a 
practical outline of what appears to be the best practices to implement (Dos) and practices to 
avoid (Don’ts) when setting up MDT-driven cancer care. 
Keywords: cancer MDT, MDM, cancer meeting, patients with cancer
Introduction
The concept of multidisciplinary team (MDT) working is widely accepted as the 
“gold standard” of cancer care delivery across the world. The cancer MDTs, and MDT 
meetings (MDMs) in particular, are at the center of an increasingly complex health 
care system. Figure 1 offers our conceptualization of modern MDT-driven care, which 
we apply to an extent to the rest of this paper. Effective MDT-driven care depends on 
a multitude of inputs (individuals, teams, environment, and patients) and processes 
(interactions, tests, results). It subsequently results in a range of outputs (patient 
experience, outcomes, organizational outcomes), which taken together are aspired to 
achieve high-quality, efficient care for patients. 
The literature describing MDT working in cancer care is diverse and increasing 
in scope and volume with an increasing number of systematic1–3,8 and other reviews.4 
The field is growing, as many disciplines alongside traditional health care effective-
ness reviewing methodology are becoming involved in understanding MDT working, 
including psychology, improvement science, organizational science, and others. The 
diversity of the evidence base in itself presents a challenge to health care  professionals, 
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patients and their advocates, as well as those involved in 
health care organization, who want to improve the care of 
patients with cancer. 
There is, therefore, need for the diverse evidence we have 
on what “works” in implementing MDTs in cancer care and 
what factors impact on care delivery to be reviewed in an 
integrated manner. This is what the present review aims to 
achieve in offering an integrative overview of diverse stud-
ies on cancer MDTs and their functioning. Specifically, the 
aim of our literature review is to synthesize current scien-
tific and clinical understanding on cancer MDTs and their 
 organization; this, in turn, should provide an up-to-date sum-
mary of the current knowledge that those planning or leading 
cancer services can use as a guide for service implementation 
or improvement. 
Methods
In order to identify the relevant literature, we undertook a 
literature search of PubMed using the search terms “decision-
making”, “cancer”, “multidisciplinary”, and “team”; we also 
hand-searched studies by consulting with experts in the field 
and by scrutinizing reference lists of retrieved papers, exist-
Figure 1 A systems model approach to improve the delivery of cancer care representing the cancer pathway with the MDM embedded within it, and various inputs and 
outputs that affect the whole of the pathway, along with the factors that can impact on the inputs (in the arrows). 
Abbreviations: Chemo, chemotherapy; rad, radiotherapy; MDM, multidisciplinary team meeting.
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MDTs in cancer care
ing reviews, guidelines, and governmental documents. The 
search was limited to human beings, English language, and 
dates of publication ranging from 1999 to September 2017. 
Overview of evidence
The retrieved evidence is organized into the following 
five domains that appear critical for effective cancer MDT 
working:
1. Background to multidisciplinary teams in cancer care.
2. Key performance indicators of effective teams and their 
meetings.
3. Factors that are known to affect team processes.
4. Assessment of cancer MDT working.
5. Improvement of cancer MDT working and its impact on 
patient care.
Background to multidisciplinary teams in 
cancer care
Cancer MDTs are made up of surgeons, oncologists, radiolo-
gists, pathologists, specialist cancer nurses, physicians, and 
meeting coordinators who usually meet on a regular basis 
(e.g., weekly) in cancer MDMs in order to discuss and agree 
on the care plan for patients with suspected or confirmed 
cancer. One of the core team members, often the MDT lead, 
tends to also chair the meeting, although variations between 
teams exist, with some not having a chair. The diagnosis 
and treatment of cancer involves a complex care pathway.5 
To ensure consistency, the UK’s Department of Health6,7 has 
made MDMs obligatory in order to ensure reliable and equi-
table delivery of safe and high-quality care that is necessary to 
improve patient outcomes – to all cancer patients. The MDM 
(sometimes termed a cancer conference or tumor board) 
is thus an integral part of cancer care services in the UK, 
where it is embedded in the cancer care pathway (Figure 1) 
and in other countries globally. It is intended to improve the 
consistency and quality of cancer care locally, regionally, and 
nationally. Even in countries where MDMs are not mandated, 
a need for a multi-team system for effective coordination of 
cancer care has been identified.1
The efficacy of the MDT-based approach to cancer care 
is poorly understood, however. Indeed, the empirical evi-
dence for MDMs is mixed and unclear,8 and their impact on 
patient outcomes, and in particular on the survival of patients 
with cancer, is uncertain. For instance, one study showed 
improvement in survival of patients with inoperable lung 
cancer from 3.2 to 6.6 months as a result of MDTs, although 
the authors noted that this could be due to other factors as 
well since cancer care is complex.9The MDT approach was 
found to encourage positive changes to care management,10 
where it was found to outperform diagnostic tests11 and lead 
to modification of diagnosis.12Other researchers, however, 
have found no difference in diagnosis pre- and post-MDM 
review.13,14More recently, research has also focused on MDMs 
identifying and improving various aspects of MDM work-
ing, such as the quality and efficacy of clinical decisions 
using methodologies ranging from surveys and interviews 
to observation and checklists (see also Table 1 for a list of 
tools available to assess MDTs that was generated from this 
evidence base).8,15–17
One reason for inconsistent results in research examin-
ing the functioning of cancer MDMs, however, could be the 
fact that novel treatments, technology, and service changes 
have all evolved in parallel to MDMs and potentially have 
confounded the findings.15 What is more, designing studies 
to assess effectiveness has proven difficult; for instance, in 
the UK, MDMs are mandatory in cancer care and, therefore, 
orthodox comparative studies, i.e., randomized controlled 
trials, are not possible.15,16 In addition, implementation of the 
MDT model of care in itself has some inherent variations 
since it relies on health care providers delivering it at the 
frontline, and this introduces human factors into the equation. 
For instance, in MDMs, decision-making process, team work-
ing and interactions, leadership (including chairing), team 
climate, treatment implementation, team ability to reach a 
care plan on a first case-presentation, and also waiting times, 
appropriate use of resources including technologies, as well 
as patient and health care professional satisfaction with care 
and quality of life, could be further examined.15,16,18 Periodic 
survival evaluation of the population as a whole as well as 
prospective longitudinal studies of treatment implementation 
may also be useful indicators of team effectiveness.19
It is, therefore, crucial to advance our understanding of 
the intended advantages of MDMs through the in-depth study 
of the behaviors, processes, context, and organization of this 
approach to patient care.19–22
Performance indicators of effective teams 
and their meetings
For a number of years after the inception of MDTs, there 
was an absence of empirical evidence about the potential 
factors that made MDTs effective. This changed in 2010 
when the National Cancer Action Team (NCAT) in England 
defined indicators for highly functioning MDTs, termed “the 
characteristics of an effective MDT”,23 including effective 
team meetings (these characteristics are outlined in Table 2). 
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Table 2 Characteristics of an effective multidisciplinary team for cancer patients
I. The Team
•	 Level of expertise and specialization 
•	 Attendance of MDMs
•	 Leadership (e.g., chair or leader of the MDMs) 
•	 Team working and culture (e.g., mutual respect and trust, equality, resolution of conflict, constructive discussion, absence of personal agendas, 
ability to request, and provide clarification) 
•	 Personal development and training
II. Infrastructure for MDM
•	 Appropriate meeting room
•	 Availability of technology and equipment
III. MDM organization
•	 Regular meetings
IV. Logistics
•	 Preparation for meetings
•	 Organization during meetings
•	 Post-meeting coordination of services for the patient
V. Patient-centered clinical decision-making
•	 who to discuss, i.e., having local mechanisms in place to identify all patients where discussion at MDM is needed
•	 Patient-centered care (e.g., patient’s views and preferences are presented by someone who has met the patient, and the patient is given sufficient 
information to make a well-informed decision on their treatment and care)
•	 Clinical decision-making process
•	 The information the team needs to make informed decisions/recommendations at team meetings are as follows: pathological, radiological, 
comorbidities, psychosocial, palliative care needs, patient history, and patient views
•	 The decisions/recommendations at team meetings need to be evidence-based (in line with NiCe and/or cancer network guidelines), patient-
centered, and in line with standard treatment protocols (unless there is a good reason against this)
VI. Team governance
•	 Organizational support (e.g., funding and resources)
•	 Data collection during team meetings, analysis, and audit of outcomes (e.g., patient experience surveys); the results of these investigations are 
fed back to MDTs to support learning and development
•	 Clinical governance (e.g., there are agreed policies, guidelines, and protocols for MDTs; performance assessment and peer review against similar 
MDTs using cancer peer review processes and other tools)
Abbreviations: MDM, multidisciplinary team meeting; MDT,multidisciplinary team;  NiCe, National institute for Health and Care excellence.
Table 1 A list of instruments used to assess and improve MDT working
Instrument 
(authors or source)
Brief instrument description Instrument 
methodology
MDT-OARS
(Taylor et al24)
“The MDT Observational Assessment Rating Scale” assesses 18 elements of good team 
functioning as expressed in national UK guidance
Observation 
TeAM 
(Taylor et al49)
“The Team evaluation and Assessment Measure” assesses core functions of the team 
and their team meetings, based on the components defined in “the characteristics of 
effective MDT”
Team self-assessment
MDT-QuiC 
(Lamb et al65)
“The MDT Quality improvement Checklist” is designed to aid decision-making in MDMs 
by ensuring that all aspects of a case are reviewed by the team
Checklist
MDT-MODe
(Lamb et al43)
“The MDT Metric of Decision-Making” measures the quality of presented patient 
information, contribution to case review per specialty, and team ability to reach a 
decision in the team meeting
Observation 
MDT Quality improvement 
Bundle 
(Lamb et al22)
A team improvement bundle including checklist application, team skills brief training, and 
guidance implementation 
Quality improvement 
bundle 
MDT-MOT
(Harris et al48)
“The MDT – Meeting Observational Tool” assesses team attendance, leadership/chairing 
of the MDM, teamwork and culture
Observation 
MDT-FiT
www.mdtfit.co.uk66
“The MDT Feedback for improving Team working” encompassing validated 
components of MDT-MOT and TeAM allows self-assessment of team working, 
combined with expert feedback from facilitator, and sharing of the outcome with the 
team as part of a team-reflective discussion 
Team self-assessment 
and observation 
Abbreviations: FiT, feedback for improving team-working; MDM, multidisciplinary team meeting; MDT, multidisciplinary team; MODe, metric of decision-making; MOT, 
meeting observational tool; OARS, Observational Assessment Rating Scale; TeAM,  Team evaluation and Assessment Measure.
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This definition was based on data from a national survey of 
over 2000 MDT members’ perceptions of effective MDT 
working. Responses showed that 90% of respondents were 
in agreement that an effective MDM results in improved 
clinical decision-making, more coordinated patient care, 
improvement in overall quality of care, more evidence-
based treatment decisions, and improved treatment. NCAT 
recommended assessing areas of team meetings such as team 
working and leadership. Key performance indicators have 
subsequently been generated from the NCAT document to 
serve as a benchmark against which MDTs can appraise and 
develop their practice.23
Moreover, the responses from the NCAT national survey 
were further analyzed by Lamb et al.15 They revealed high 
agreement between different cancer teams (116 out of 136 
agreements) in terms of what constitutes effective MDT 
working. Nonetheless, subtle variations in team working and 
clinical decision-making were evident across different tumor 
types and in relation to the preparation for and organization 
of MDMs, case selection, and clinical decision-making 
process.15
The “characteristics of an effective MDT” were further 
examined a few years later by Taylor et al49 while developing 
a series of teamwork formative assessment tools: MDT MOT, 
TEAM, and MDT FIT (Table 1). When testing these tools, 
Taylor et al49 confirmed the robustness of the characteristics 
as a benchmark that was applicable to rarer cancers (such 
as pediatric, brain, and hematology) in teams that faced 
challenges or complex situations and in MDMs that video-
conferenced using multiple sites.49,24
More recently in 2017, a Cancer research UK report on 
cancer MDTs reiterated that team members expressed a high 
regard for MDMs, their structure, and process.25 The majority 
of participants valued the meetings stating that they not only 
facilitated patient care but also saved them considerable time 
elsewhere in their clinical or administrative practice.
Factors that are known to affect team 
processes
A number of studies have explored factors that have an impact 
on how well cancer MDMs function; these are related to the 
“input” element of the input-process-output diagram pre-
sented in Figure 1. Research into their working was greatly 
advanced by Lamb et al who developed a systems approach 
in 2010 to understand the multiple factors that can affect 
MDMs (Figure 2).26 This ordered structure was then used as 
a basis for assessing the efficient functioning of an MDM 
and designing assessment tools for MDMs to improve team 
working and the delivery of cancer care (Table 1). They also 
performed content analysis on the responses to free-text 
(open) questions pertaining to the effectiveness of MDM 
working from the 2009 national survey of MDT members 
in the UK.27 These questions covered three topics: effective 
team-working in the meetings, efficacy of team decision-
making, and patient centeredness. This analysis aimed to 
further define aspects of effective team working in MDMs, 
with an emphasis on the similarities and differences in views 
between different professional groups. 
The authors raised specific questions/issues regarding 
MDM functioning that could provide an evidence base 
Figure 2 A systems approach to describe and evaluate the functioning of an MDM. Reprinted from Surgical Oncology. 2011;20(3):163–168. Lamb Bw, Green JSA, vincent C, 
Sevdalis N. Decision making in surgical oncology with permission from elsevier.26
Abbreviations: GP, General Practitioner; MDM, multidisciplinary team meeting; MDT,multidisciplinary team.
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on which MDTs can develop their practice. Specific areas 
highlighted included the following: 1) how best to represent 
patients’ views in MDM, 2) how disagreements within the 
team should be dealt with, and 3) what are the factors that 
facilitate participation in the decision-making process in 
team meetings, including organizational (e.g., lack of time to 
prepare) and interpersonal factors (e.g., steep hierarchies and 
lack of trust or respect between team members). It is argued 
that failure to optimize these factors can have an effect on 
clinical decision-making and could account for the variability 
seen in how well MDMs work. 
Another contribution to our understanding of the factors 
that affect the impact of cancer MDTs on patient care comes 
from a systematic review8 performed on 37 studies published 
between 2000 and 2008. It was found that MDTs failed to 
reach a decision for 27%–52% of cases and that when deci-
sions were made they could not be implemented in 1%–16% of 
cases. The study showed that1) care management decisions are 
made predominantly by medical personnel (usually surgeons), 
while nursing personnel have less of an active role in decision-
making and defining treatment options, and patient preferences 
are rarely discussed and 2) time pressure (including lack of 
protected time to prepare for meetings), excessive caseload, low 
attendance, poor team working, and lack of leadership lead to 
lack of information and deterioration of decision-making. Some 
of these factors were reiterated in the 2017 Cancer Research 
UK (CRUK) report (time pressure, expanding workload, and 
lack of protected time) nearly 10 years later.23
In what follows, we describe in detail the factors affecting 
MDT working, including factors that impact on MDMs as 
per “input” in Figure 1.
Personal and team skills
Good relationships between team members and adequate 
non-technical skills are important for smooth effective 
MDT functioning (i.e., communication and leadership). In 
particular, communicating effectively with colleagues at 
various levels of hierarchy and managing conflict within 
teams are recognized as key contributors to safe, high-quality 
care delivery across specialities.23 However, evidence shows 
unequal participation in discussions on treatment options 
with medical personnel (including, e.g., oncologists and 
surgeons) tending to base their care management decisions 
primarily on biomedical information, seldom considering 
patient choice. It was also shown that nurses contribute to 
the meetings with the information about the patient’s views 
and psychosocial aspects of care, although traditional profes-
sional hierarchies often lead to the exclusion of nurses and 
bias toward biomedical information.8,27 An interview study 
exploring the views of surgeons, oncologists, nurses, and 
administrators on various characteristics of MDMs has found 
that patient discussions do not encompass the contributions of 
different disciplines equally, i.e., nurses are underrepresented 
and surgeons, who dominate discussion, are biased toward 
biomedical information. 
Effective leadership of an MDT, which includes chairing 
of team meetings, can play an important role in ensuring 
equality and inclusiveness of participation that may enable 
better decision-making. Nontechnical skills (e.g., commu-
nication skills) as well as clinical expertise were cited as 
key characteristics of an effective meeting chair. Training in 
nontechnical skills may be of benefit, in particular because 
the chair does not necessarily need to be a surgeon since 
other core members with adequate skill could take on this 
role.28 Some of the best MDMs observed during the develop-
ment phase of the MDM assessment tools mentioned earlier 
(Table 1) were chaired by specialist cancer nurses – core team 
members in MDMs. 
When nurses are actively involved in care planning 
in the meetings, the team is perceived as performing at a 
higher level. Similarly, teams report that presence of nursing 
staff and larger and more diverse teams is associated with 
increased effectiveness.8,29 Nurses tend to involve patients’ 
views in the decision-making process more than medical 
personnel do. This is important since only 4% of MDM 
discussions involve patient’s holistic information directly in 
the decision-making process.29 In addition, evidence shows 
that decisions that take into account patients’ preferences, 
performance status, and comorbidities are more likely to 
be implemented since such decisions are more clinically 
appropriate and acceptable to patients.30,31,27 A more recent 
study showed that a complete patient profile (including, the 
biomedical aspects of the disease, as well as the information 
on patients’ co-morbidities, their psychosocial aspects, and 
views on treatment options), and input into the discussion 
by all core disciplines (including, the nurses’) are essential 
for the team to formulate a treatment recommendation for 
a patient.18,32 And the need for a higher level information 
on patient comorbidities and nursing input may actually be 
indicators of more complex discussions18 and validates the 
inclusion of specialist cancer nurses in the core membership 
of the MDMs.
The coordinators in cancer MDMs (for systems that 
afford this role within the team) also have an important role 
in improving the quality of care delivered by MDTs through 
their effect on team effectiveness and climate. However, their 
administrative role, as an intrinsic part of the cancer team, is 
often undervalued. The job is often used as an initial entry 
 
Jo
ur
na
l o
f M
ul
tid
isc
ip
lin
ar
y 
He
al
th
ca
re
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
15
5.
19
8.
12
.1
89
 o
n 
23
-M
ar
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Journal of Multidisciplinary Healthcare 2018:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
55
MDTs in cancer care
into working in the health system and many of the coordina-
tors, therefore, have little previous health service experience. 
A survey has found that coordinators feel that their job plan 
does not reflect their actual duties.33 They identified needs for 
further areas of training in oncology, anatomy, physiology, 
and leadership skills to improve their team performance and 
consequently cancer care. Their role is central to the care of 
patients, both locally and through the coordination and shar-
ing of data on wider level. Since coordinators role is pivotal 
in MDMs, it is important to devise and provide them with 
adequate training in order to improve team performance as a 
whole, something further research could focus on.33
Another issue raised by Lamb et al27 was the importance 
of recording the disagreements when they occur and poten-
tially discussing them with the patient. Although disagree-
ments are uncommon in MDMs, dissent is not detrimental 
to a team as it can enhance critical thinking and evaluation 
during decision-making. However, teams that do not tend to 
dissent are at risk of “group think”, where disagreement exists 
but are not openly expressed; this may indicate poor team 
climate and lack of open communication within a team that 
can lead to poor decision-making. Within an MDM, ensur-
ing open communication where dissent is acknowledged and 
effectively managed may be a key element of the chair’s role. 
Further research is nonetheless needed to evaluate how often 
and where dissent occurs in meetings and how it should be 
managed and collated and how it should be communicated 
to the patient.27
Team members report that MDMs are generally highly 
positive with an open culture for discussion, optimal man-
agement plans, coordinated treatment, and low risk of error. 
Moreover, a rotating leadership, which refers to team mem-
bers taking turns at chairing the meeting, was found to be 
highly effective in terms of improving team work and team 
morale and reducing inter-professional conflict, although 
MDMs are most commonly led by surgeons. However, the 
role of the chair is unequally (and irregularly) distributed 
across disciplinary groups within a MDM, although, disci-
plines other than surgeons may be able to undertake this role..8
To illustrate this fact, a recent study from Scotland, exam-
ining the efficacy of a specialist nurse leading a cancer MDT 
by comparing clinical outcomes, showed that the nurse-led 
MDT performed as well if not better than other local units 
with comparable resources and patient population led by 
surgeons.35 Other disciplines such as oncology have high 
levels of contribution to MDM decision-making. But regard-
ing their role in leadership, when surveyed, they thought that 
they could chair the team meeting as readily as any other 
professional group. However, they are not taking leadership 
role at the level that they expect; for example, only one in 
four oncologists has been chair of the MDT they attend and 
<40% of the MDMs they attend have a rotating chairman-
ship, further reducing the opportunity to lead. This prospect 
is further complicated by the finding that the oncologists who 
responded tend to participate in at least three MDMs, placing 
more demand on their time and ability to prepare and attend.18
It may, therefore, be useful to have a clinically non-
contributing member chair the meeting to avoid detriments 
in performance as a result of a dual-task interference, as the 
job of chairing the meeting, by a clinician, has the potential 
to diminish the contribution that the clinician can then make 
to decision-making, during the meeting.18
environment
While non-technical skills are important, they are not suf-
ficient on their own. Support at an organizational level is also 
important in the form of protected time in the participants’ job 
plans to prepare for, attend, and take action on the workload of 
the meeting. Lamb et al34 found that lack of protected time for 
team meetings and competing demands or frequent conflicts 
with other responsibilities were barriers to effective meetings. In 
particular, team members without protected time for meetings 
were less likely to attend,27 and that the most frequently cited 
organizational improvement to MDT working was more time 
dedicated to prepare for and attend the MDM.25 Further research 
or audit is needed at an organizational level to ensure that 
protected time is available and supported organizationally.27,25
Excessive time pressure and lack of, or inadequate, infor-
mation available at the time of decision-making (including 
imaging, investigations of tumor stage, review of pathol-
ogy, and comorbidities) was found to negatively affect team 
ability to reach definitive care management plan, and lower 
team morale, resulting in reduced attendance and rushed 
decision-making. Compounding this, lack of protected time 
for MDMs to prepare for meeting contributes to excessive 
workload, time wasting during meetings, and inefficiency.8,25
Technology and decision support systems also play an 
important role. Telemedicine improves meeting attendance 
and it is cost-effective. However, it can slow down the team 
by reducing the number of patient discussed per meeting34 
and can negatively affect team’s decision-making.16
Patient
Lack of patient-centered information presents a barrier to 
decision-making too; that is, failure to consider such infor-
mation inhibits decision-making, renders decisions clinically 
inappropriate or unacceptable to patients, and is therefore 
detrimental to patient care.27 Patients should be represented 
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by team members who know them well. Findings suggest 
that the clinical nurse specialist is the preferred team member 
to represent the patients’ views in meetings, but consultant 
and attending surgeon or other members could also share 
the duty. Having patients present in MDMs might arguably 
inhibit the process; hence discussions between the patient 
and team members following the main MDT discussion may 
be preferable.27 Nonetheless, patient-centeredness is impor-
tant; a more recent study showed that patient psychosocial 
information is a significant predictor of team ability to reach 
a decision32 and that a complete patient profile is needed for 
the treatment recommendation to be formulated.18
Further research is needed to gain better understanding of 
how to best integrate patient-centered information into MDM 
decision-making – a task that is not necessarily straightfor-
ward. This is because patient preferences will vary according 
to the disease itself, personal values, and circumstances.27 
Moreover, it is not clear whether it is in the patient’s best 
interest that their preferences form part of the decision-
making process or whether the team should initially discuss 
clinical options before patient preferences are considered.27 
In addition, any preferences patients express before the full 
MDM might change according to the advice and reflections 
emanating from the meeting.27
As a final point, Jalil et al16 investigated views of expert 
urology and gastrointestinal cancer service providers in rela-
tion to the effectiveness of their MDMs in reaching a decision 
for each patient, with a particular emphasis on identifying 
the barriers to implementing MDT decisions into patient 
care and how these can be overcome. The researchers used 
semi-structured interviews with MDT members of urological 
and gastrointestinal tumors. It was found that 92% of patient 
management plans are formed at MDMs and 95% of these 
are subsequently implemented. The list of factors impacting 
decision-making and implementation and those that can help 
improve it are given in Table 3.
Assessment of cancer MDT working
Studies show that MDM’s decision-making ability and the 
success in reaching a treatment plan when first reviewing a 
patient are good markers of the quality of teamworking.16,8,34,36 
Teams’ choice of treatment and the implementation of these 
recommendations (rather than survival rates which are dif-
ficult to directly attribute to MDM working) can also be 
measured. Hence, a number of observational assessment 
tools have been designed to help measure and subsequently 
improve the impact of cancer MDMs on patient care. As such, 
observational approaches to MDM working are useful, fea-
sible, and non-intrusive (i.e., do not intrude on patient time or 
add to team workload), providing an opportunity to perform 
out assessments in real-life setting and understand areas in 
which the MDMs are doing particularly well and those that 
need further improvement. Such approaches were developed 
on the backdrop of a growing tradition within health care 
for the use of observational evaluations of team skills and 
performance in both clinical environments, e.g., operating 
theaters,37 intensive care units,38 emergency departments,39 
and within simulated settings.40 Overall, this is based on the 
premise that team assessment and feedback can help teams 
reflect on their own performance and improve their working. 
However, observational methodology has its drawbacks. 
For example, it can be time consuming, lacks insight into 
Table 3 A list of factors impacting and improving decision-making and implementation
I. Factors impacting decision-making and implementation
•	 Lack of necessary information
•	 Lack of considerations of patient comorbidities, choices, and disease progression
•	 Non-attendance of key team members (as this can delay the decision and/or making a decision without the key team member can lead to an 
inappropriate treatment plan)
•	 Time pressure, i.e., not enough time to discuss all the patients, and so some get deferred (this can also negatively impact the patients)
•	 Technological problems with video conferencing
II. Factors improving decision-making and implementation
•	 Better case preparation, e.g., with a pro forma
•	 effective team leadership (and chairing)
•	 Involvement of an anesthetist in the MDM (to immediately discuss whether patient is fit for surgery)
•	 Not discussing all patients, i.e., refining the inclusion criteria for MDT discussion either by splitting MDM into smaller meetings (logistical 
difficulties with this approach) or by excluding patients that fall under clear protocol/guidelines (although outside mandatory practice, this should 
be considered in future)
•	 Inclusion of patients in MDMs – however, there are mixed findings as to the benefit to the patient, and due to practical difficulties, patients in the 
UK do not attend
Abbreviations: MDM, multidisciplinary team meeting; MDT,multidisciplinary team.
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what participants think or feel, lacks control over extrane-
ous factors, can present with limited replicability, and poses 
a challenge for a researcher to be accepted (non-clinical 
researcher) or to distance themselves from the environment 
(clinical researcher). Using structured and validated obser-
vation instruments by trained observers and ensuring good 
interobserver reliability can help adequately address these 
drawbacks. This is important, because, on balance, obser-
vation of MDTs is an important methodological approach 
to study such complex organizational behavior and to 
help improve safety and quality. Table 1 presents a list and 
 description of tools designed and used for assessing MDTs 
together with study examples.
In the past few years, numerous studies have been 
performed applying observational techniques to better 
understand, assess, and improve MDT working. A number 
of studies have used a validated observational tool, MDT-
MODe (Metric for the Observation of Decision-making in 
cancer multidisciplinary teams), to assess decision-making 
processes across different specialties, including the breast, 
urology, lung and colorectal cancers.18,32,41,42,44–47  For instance, 
Lamb et al22 revealed that the ability of an MDT to reach a 
clinical decision was positively associated with high-quality 
comprehensive and necessary information available at the 
point of decision-making (from case history, radiology, 
pathology), team contribution, and cases that are discussed 
at the beginning of meetings. However, high-quality informa-
tion and team contribution were positively correlated with 
the larger team size, higher number of cases per meeting, and 
longer case discussions. Furthermore, using MDT-MODe, 
Soukup et al18,22 found that a complete patient profile and 
representation by all core disciplines are necessary to maxi-
mize the ability of an MDM to reach management recom-
mendations for all cases. More recently, MDT FIT has been 
developed as a web-based self-assessment tool for use by 
UK cancer teams to assess themselves locally and region-
ally by using validated instruments such as MDT MOT48 and 
TEAM49embedded within them (Table 1). 
In addition, there are developed and validated instruments 
within the social sciences that, although have not been specifi-
cally developed for cancer MDMs, could be profitably used 
in this context. For instance, the Team Climate Inventory,46 
a short questionnaire, can provide insight into individual 
members’ perspectives of their team dynamics and has been 
successfully used with cancer MDTs.17 Bales Interaction 
Process Analysis51 is an observational coding system devel-
oped with small groups engaged in a problem-solving task (a 
context that resembles MDMs). It measures socioemotional 
(e.g., showing solidarity or tension) and task-related areas 
(e.g., giving suggestions and asking for opinion), and it has 
been successfully used as an observational assessment tool 
with MDTs.50–54 Team interactions can also be assessed using 
conversation analysis, which allows detailed examination 
of communication between members from audio- or video-
recorded data transcribed using Jefferson notation system55 
that captures not only what is said but also how it was said 
with symbols indicating various aspects of talk, includ-
ing intonation, pauses, overlaps, gaps, pace, loudness, and 
cut-offs, for instance. It has been previously used to study 
MDTs in the context of weekly meetings,56,57as well as in the 
operating theater.58,59 Overall, these are untapped translational 
resources that could be profitably used to gain better under-
standing of team processes and dynamics and allow effective 
assessment of different levels of MDT working.
improvement of cancer MDT working 
and its impact on patient care 
Some of the assessment tools described earlier has been used 
in intervention packages. For instance, Lamb et al22 per-
formed an intervention study that encompassed the following: 
1) half-day training session on the evidence for improved 
clinical decision-making followed by an interactive workshop 
and discussion, 2) MDT QuIC to support decision-making, 
3) training session for surgical residents on how to use MDT 
QuIC to prepare and structure cases in advance of the team 
meeting, and 4) guidance to the team by providing hardcopy 
and via e-mail setting out how team members could draw 
optimal clinical information required for decision-making. 
These interventions were found to improve decision-making 
and the likelihood of the team formulating a clinical man-
agement plan, both necessary for high-quality patient care. 
Decision support tools, such as the MDT-QuIC, were also 
shown to improve patient care and increase compliance with 
clinical practice guidelines. MDT FIT, a self-assessment tool 
mentioned earlier, was also designed to be an intervention to 
improve cancer team working and thus ultimately the delivery 
of enhanced patient care. Since its inception, it has proven 
useful to all UK cancer teams that have used it and everyone 
has found areas for improvement.60
Based on the flourishing area of team assessment and 
improvement tools that have been developed and applied in 
the past few years, we are optimistic that interventions that 
combine best evidence as found elsewhere in health care, 
such as combinations of skills training and checklist applica-
tion, possibly using simulation as a training approach61 will 
find their way into MDM improvement in the coming years. 
Health services have changed significantly since MDTs 
were introduced 20 years ago. There has been a sustained 
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increase in the workload of MDTs as a result of growing 
number of patients to be discussed in MDMs, along with the 
complexities of an aging population and growing number of 
treatment options available.25 The increase in the demand for 
MDT working has not been matched by greater availability 
of resources, with only minor increases in capacity seen. One 
potential solution, which has been identified by researchers 
and policymakers alike, is to streamline MDM working62,63,25 
to allow more straightforward cases to assign less discussion 
time. This strategy might allow more time and resources in 
MDMs for discussion of complex or rarer cases, where patients 
have unusual or multiple problems requiring a truly multidisci-
plinary approach. Combined with the initiatives to improve the 
quality of MDT working, such a strategy, could help optimize 
the MDT approach for those patients in need of it.64
Summary
As a central part of the care pathway, cancer MDMs are a 
clinically valued resource allowing a diverse range of health 
care experts, necessary for an increasingly complex cancer 
care, to come together and discuss treatment options for 
patients. They are an expensive resource, however, and with 
an increase in the health and economic pressures, its value 
has been progressively placed under scientific scrutiny. 
The past decade has thus seen research on cancer MDTs 
rapidly evolving. The lack of empirical evidence led to the 
NCAT’s characteristics of effective teams. This was followed 
by an array of studies examining various aspects of team 
functioning; they encompass observational approaches and 
tool developments, but also surveys and interviews assessing 
the team members’ and patients’ perspectives on MDTs. The 
importance of weekly MDMs for cancer MDTs was further 
reiterated recently in the report by the CRUK. 
While evidence has consistently shown variations in 
team working and clinical decision-making across different 
cancers, we have learned that certain factors pertaining to 
personal and team skills, the environment and patient-cen-
teredness can impact team functioning and decision-making 
(Tables 3 and 4). Hence the importance of a team-centered 
approach to improving cancer MDMs; led by a clinically 
feasible, observational methodology, and adequate training 
opportunities in non-technical skills.
What is more, we have also grown to think of MDMs as 
an input-process-output model. This provides a necessary 
framework that allows the design and execution of studies nec-
essary for producing and accumulating the knowledge base, 
thereby steadily building our understanding of what practices 
MDTs should reinforce and avoid. Table 4 below presents a 
summary of these practices as mentioned within our review.
Strengths and limitations of the 
review
Regarding limitations, this review is a summary of current 
understanding – academic and clinical – of cancer MDT 
working; due to the heterogeneity of the studies, metrics, 
and outcomes we reviewed, a fully systematic review meth-
odology was not feasible. Furthermore, in being inclusive 
of different designs and methods and adopting a descriptive 
approach, we did not assess the methodology and analyses 
undertaken within the studies that form the evidence for this 
review. Strengths of the review include that it offers a sum-
mary of a very disparate evidence base and it covers validated 
metrics for the evaluation of MDT work processes. 
Conclusion
This review presents an up-to-date summary of the recent 
literature on the impact of cancer teams on the management 
of patients with cancer. We hope that this review will serve 
as a comprehensive reference document for health care 
professionals, patients, and their advocates, as well as those 
involved in the organization of cancer services, to enable 
them to critically evaluate and improve multidisciplinary 
team working in their own domain. MDTs are essential to 
Table 4 Practices to implement (Dos) and those to avoid 
(Don’ts) when setting up MDT-driven cancer care
Dos Don’ts
Good relationships between 
team members
Unequal participation in discussion 
on treatment options
Communicating effectively with 
colleagues
Basing decisions primarily on 
biomedical information
Managing conflict within teams 
effectively
Seldom considering patient choice
incorporating patient choice into 
decision-making
–
incorporate patient views on the 
treatment options into decision-
making
–
incorporate patient psychosocial 
factors into decision-making
–
incorporate patient 
comorbidities into decision-
making
–
ensuring equality and 
inclusiveness of team 
participation, in particular nurses
–
Rotating chairing duties within 
and between disciplines and, 
where possible, have a clinically 
non-contributing individual chair 
the meeting
–
Abbreviation: MDT, multidisciplinary team.
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cancer care, and cancer MDMs are a particularly important 
part since they allow the team with a diverse range of clinical 
specialties to come together and formulate treatment recom-
mendations for patients with suspected or confirmed cancer. 
A range of factors pertaining to teamwork, availability of 
patient information, leadership, meeting management, 
and workload can affect the impact of an MDM on patient 
care. Studies to date have demonstrated that measuring and 
improving MDM working is possible and that improvements 
in patient care can be achieved as a result.
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